Description

Alboraie et al reported the Egy Score for identifying a patient with chronic liver disease who may have hepatic fibrosis. This is a noninvasive method that can help to identify a patient who may need to be worked up further. The authors are from Al-Azhar University, Cairo University and Zagazig University in Egypt.


 

Patient selection: Egyptian with chronic liver disease

 

Outcome: hepatic fibrosis

 

Parameters:

(1) CA 19-9 in U/mL

(2) age in years

(3) alpha-2 macroglobulin in g/L

(4) serum total bilirubin in µmol/L

(5) platelet count in 10^3/µL

(6) serum albumin in g/L

 

Egy score =

= (0.0063 * (CA 19-9)) + (0.0203 * (age)) + (0.4485 * (alpha-2 macroglobulin)) + (0.0303 * (bilirubin)) - (0.0048 * (platelet count)) - (0.0462 * (albumin)) + 3.52

 

An Egy score > 2.91850 was 76% sensitive and 68% specific for significant hepatic fibrosis (F2, F3 or F4), with a negative predictive value of 100%. The positive predictive value was 80%. The area under the ROC curve was 0.78.

 

An Egy score > 3.28624 was 92% sensitive and 78% specific for severe hepatic fibrosis (F3 or F4), with a negative predictive value of 97%. The positive predictive value was 56%. The area under the ROC curve was 0.88.

 

An Egy score > 3.67570 was 82% sensitive and 87% specific for cirrhosis (F4) with a negative predictive value of 97%. The positive predictive value was 43%. The area under the ROC curve was 0.87.

 

Limitations:

• All of the assays need to be performed accurately and precisely in order to get reliable calculations.

 


To read more or access our algorithms and calculators, please log in or register.